For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
MedicalXpress Breaking News-and-Events | Jun 06, 2023
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer
MedicalXpress Breaking News-and-Events | Jun 06, 2023
Billions spent on cancer research but only small percentage goes to treatment, study shows
MedicalXpress Breaking News-and-Events | Jun 03, 2023
Specifically designed diets demonstrate a 'powerful ability' to prevent tumorigenesis, delay tumour growth
MedicalXpress Breaking News-and-Events | Jun 03, 2023
Using high-res images to detect precancerous cervical lesions
MedicalXpress Breaking News-and-Events | Jun 03, 2023
Personalizing prostate cancer screening may improve the accuracy of detection
MedicalXpress Breaking News-and-Events | Jun 03, 2023
How mutations to a key liver cancer pathway contribute to tumour progression
MedicalXpress Breaking News-and-Events | Jun 03, 2023
Open-analysis platform for pediatric brain tumours provides robust data resource for childhood cancer research
MedicalXpress Breaking News-and-Events | Jun 02, 2023
Researchers develop new CRISPR-based tool for cancer diagnosis
MedicalXpress Breaking News-and-Events | Jun 02, 2023
Novel bioassay predicts cancer patients' response to immunotherapy
MedicalXpress Breaking News-and-Events | Jun 02, 2023